Dicyclomine

Primary Uses

Dicyclomine is primarily prescribed to manage the symptoms of functional bowel disorders, specifically irritable bowel syndrome (IBS). It belongs to a class of medications known as anticholinergics or antispasmodics.

How It Works

The medication works by relaxing the smooth muscles found in the stomach and intestines. By preventing or reducing sudden muscle contractions (spasms), it helps alleviate several symptoms associated with IBS, including:

• Abdominal pain
• Stomach cramping
• Bloating
• Changes in bowel habits

Dicyclomine is often used as one part of a broader treatment approach for IBS, which may also include dietary modifications, stress management, and other lifestyle changes. It is intended to treat the symptoms of the condition rather than provide a cure.

Mechanism of Action

Dicyclomine belongs to a class of medications known as anticholinergics or antispasmodics. It works primarily by blocking the action of acetylcholine, a natural chemical messenger in the body that signals muscles to contract. By interfering with these signals, the medication helps to prevent or reduce muscle spasms in the gastrointestinal tract.

Effects on the Digestive System

When the muscles in the digestive system contract too frequently or too forcefully, it can cause pain, cramping, and discomfort. Dicyclomine helps manage these symptoms through two main actions:

• Blocking nerve signals: It stops acetylcholine from binding to specific receptors on the smooth muscles of the stomach and intestines.
• Direct muscle relaxation: It has a direct relaxing effect on the smooth muscles themselves, which helps to slow down the movement of the gut.

By relaxing these muscles, dicyclomine reduces the intensity of contractions, which helps alleviate the abdominal pain and cramping often associated with functional bowel disorders like irritable bowel syndrome.

Common Side Effects

• Dizziness or lightheadedness
• Drowsiness
• Blurred vision
• Dry mouth
• Nausea
• Constipation
• Weakness
• Nervousness

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious side effects:

• Confusion, hallucinations, or unusual thoughts and behavior
• Fast or pounding heartbeats
• Difficulty urinating or decreased frequency of urination
• Decreased sweating, which can lead to overheating and heatstroke in hot environments
• Severe constipation or abdominal bloating
• New or worsening diarrhea
• Signs of an allergic reaction, such as skin rash, hives, or swelling of the face, lips, or tongue

Older adults may be more sensitive to certain side effects, particularly confusion, agitation, or excessive drowsiness.

Major Warnings

Dicyclomine can cause serious side effects affecting the central nervous system, including confusion, disorientation, short-term memory loss, hallucinations, and extreme sleepiness. These symptoms usually resolve within 12 to 24 hours after stopping the medication.

Heat Sensitivity

This medication can decrease sweating, which increases the risk of heat exhaustion and heat stroke. It is important to avoid becoming overheated during exercise or in hot weather, as the body may be less able to cool itself down.

Contraindications

Dicyclomine should not be used by individuals with certain health conditions, including:

• Obstructive diseases of the gastrointestinal tract or urinary tract
• Severe ulcerative colitis
• Reflux esophagitis
• Glaucoma
• Myasthenia gravis
• Unstable cardiovascular status in acute hemorrhage
• Infants under 6 months of age

Precautions

Caution is advised for individuals with the following conditions:

• Kidney or liver impairment: The drug is processed by these organs, and dosage adjustments or close monitoring may be necessary.
• Heart conditions: Dicyclomine may increase heart rate, which can be problematic for those with heart disease, congestive heart failure, or high blood pressure.
• Prostatic hypertrophy: The medication may cause urinary retention in those with an enlarged prostate.
• Autonomic neuropathy: This condition may affect how the body responds to the medication.

Dicyclomine may cause drowsiness or blurred vision. Activities requiring mental alertness, such as driving or operating machinery, should be approached with caution until the effects of the medication are known. Alcohol should be avoided as it may increase the sedative effects of the drug.

Pregnancy

There is limited information regarding the safety of using dicyclomine during pregnancy. While animal studies have not shown a risk of harm to the fetus, there are no adequate and well-controlled studies in pregnant women. This medication should be used during pregnancy only if the potential benefit justifies the potential risk. If you are pregnant or planning to become pregnant, discuss the risks and benefits with your healthcare provider.

Breastfeeding

Dicyclomine is known to pass into breast milk. Because of the potential for serious side effects in nursing infants, breastfeeding while taking this medication is generally not recommended. Reported risks to infants include:

• Breathing difficulties or shortness of breath
• Seizures
• Loss of muscle tone
• Fainting or coma

Additionally, dicyclomine may interfere with the body's ability to produce breast milk. Consult your doctor to discuss alternative treatments or feeding options if you need to take this medication while breastfeeding.

Available Forms

Dicyclomine is provided in various formulations for both oral and injectable use:

• Oral Capsules: Solid capsules taken by mouth.
• Oral Tablets: Solid tablets taken by mouth.
• Oral Solution: A liquid or syrup formulation taken by mouth.
• Intramuscular Injection: A solution for injection administered into a muscle by a healthcare provider.

The injectable form is generally reserved for short-term use in patients who are unable to take the medication by mouth.

FDA Approval Status

Dicyclomine hydrochloride was first approved by the U.S. Food and Drug Administration (FDA) in the 1950s. It is currently approved for the treatment of functional bowel or irritable bowel syndrome (IBS). It is available in various forms, including oral capsules, tablets, syrup, and intramuscular injection.

Approved Indications

The primary FDA-approved indication for dicyclomine is the treatment of functional bowel/irritable bowel syndrome. It is used to manage symptoms by reducing spasms in the muscles of the digestive tract.

Regulatory Warnings and Contraindications

While dicyclomine does not have a boxed warning, the FDA has issued significant safety contraindications and warnings regarding its use:

• Infant Contraindication: Dicyclomine is strictly contraindicated in infants less than 6 months of age. Serious respiratory reactions, including shortness of breath, gasping, and syncope, as well as seizures and death, have been reported in this age group.
• Other Contraindications: The medication is also contraindicated in patients with obstructive uropathy, obstructive disease of the gastrointestinal tract, severe ulcerative colitis, reflux esophagitis, glaucoma, and myasthenia gravis.
• Cardiovascular Warning: It is contraindicated in patients with unstable cardiovascular status in acute hemorrhage.

Controlled Substance Status

Dicyclomine is not a controlled substance under the Controlled Substances Act. It is available by prescription only and is not considered to have a high potential for abuse or addiction.

Managing Discontinuation

If you have been taking dicyclomine for an extended period, stopping the medication suddenly may cause withdrawal symptoms. These reactions are generally not life-threatening but can be uncomfortable.

Commonly reported withdrawal symptoms include:

• Dizziness
• Nausea
• Vomiting
• Sweating

To minimize the risk of these effects, healthcare providers typically advise a gradual reduction in dosage rather than an immediate stop. Always follow your doctor's instructions regarding how to taper off the medication safely.